ASCO 2026 Webinar: Promising Advances in Gastric Cancer Treatment

In this webinar, leading stomach cancer experts share the most promising treatment advances presented at the 2026 ASCO Annual Meeting. The discussion highlights exciting developments in HER2-positive gastric cancer, including encouraging results from new combination therapies featuring Ziihera, as well as emerging targeted treatments like savolitinib for MET-positive tumors. The panel explores how advances in precision medicine, genetic testing, and innovative therapies are creating new hope for patients and improving long-term outcomes for those living with gastric cancer.

Watch the recording on Youtube